Avertile Pharmaceuticals Private Limited
About Avertile Pharmaceuticals Private Limited
Data last updated:
Avertile Pharmaceuticals Private Limited is a private limited company based in Saharsa, Bihar, India. It operates in the equipment and supplies segment of the industrial equipment and machinery sector. It was incorporated on 30 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51507BR2021PTC053732.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anupriya Kumari and Kumari Anupama.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Sarita Singh W/O Pranjal Kumar Singh Santnagar Ward No – 15 Gangjala Kahara, Saharsa, Bihar, India – 852201.
Company details
Contact details
Avertile Pharmaceuticals Private Limited's registered office is in Saharsa, Bihar.
- Registered AddressC/O Sarita Singh W/O Pranjal Kumar Singh Santnagar Ward No – 15 Gangjala Kahara, Saharsa, Bihar, India – 852201
- IndustryEquipment & Machinery, Equipment And Supplies, Machinery, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Avertile Pharmaceuticals Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Avertile Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avertile Pharmaceuticals Private Limited
Avertile Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupriya Kumari | Director | 30 Aug 2021 | 5 Years 2 Months | Current |
| Kumari Anupama | Director | 30 Aug 2021 | 5 Years 2 Months | Current |
| Sarita Singh | Director | 30 Aug 2021 | 5 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Avertile Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avertile Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avertile Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avertile Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anupriya Kumari was appointed as Director on 30 Aug 2021.
Frequently asked questions
Avertile Pharmaceuticals is an active private limited company based in Saharsa, Bihar, India. The company works in equipment and supplies, within the equipment and machinery industry. It was incorporated on 30 August 2021 (5+ years old) and is registered under CIN U51507BR2021PTC053732.
Avertile Pharmaceuticals has 3 current directors:
- Anupriya Kumari - Director
- Kumari Anupama - Director
- Sarita Singh - Director
The latest financial statements of Avertile Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Avertile Pharmaceuticals is U51507BR2021PTC053732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avertile Pharmaceuticals was incorporated on 30 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
Anupriya Kumari was appointed as Director on 30 Aug 2021. Kumari Anupama was appointed as Director on 30 Aug 2021. Sarita Singh was appointed as Director on 30 Aug 2021.
The registered office of Avertile Pharmaceuticals is at CO Sarita Singh WO Pranjal Kumar Singh Santnagar Ward No – 15 Gangjala Kahara, Saharsa, Bihar, India – 852201.
Avertile Pharmaceuticals operates in the equipment and machinery industry, in the equipment and supplies segment.
Avertile Pharmaceuticals can be reached at its registered office: CO Sarita Singh WO Pranjal Kumar Singh Santnagar Ward No – 15 Gangjala Kahara, Saharsa, Bihar, India – 852201.
Avertile Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Patna.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
